Investing Ideas
/
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies

Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies with a Value score of at least 3, ordered by Value score

8 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MRK Merck	US$102.80	0%	1.8%	US$248.0b	US$134.96	PE20.4x	E16.0%	3.3%
TMO Thermo Fisher Scientific	US$607.50	0%	17.6%	US$200.4b	US$755.92	PE32.7x	E11.5%	0.3%
BMY Bristol-Myers Squibb	US$59.80	0%	-17.7%	US$116.3b	US$63.53	PS2.5x	E48.7%	4.3%
GILD Gilead Sciences	US$96.32	0%	27.0%	US$115.4b	US$102.93	PE915.6x	E40.7%	3.3%
REGN Regeneron Pharmaceuticals	US$1,062.75	0%	n/a	US$75.5b	US$1,594.58	PE16.2x	E6.9%	n/a
PFE Pfizer	US$26.43	3.6%	-6.0%	US$149.4b	US$31.95	PE35x	E14.8%	6.4%
AMGN Amgen	US$264.80	0%	n/a	US$141.6b	US$324.17	PE33.5x	E18.5%	3.6%
JNJ New Johnson & Johnson	US$145.33	-2.5%	-5.4%	US$347.8b	US$175.32	PE23.6x	E10.6%	3.4%

Page 1 of 1